Close Menu
Home » Ciphergen, MD Anderson Cancer Center, NIH, Lumera, Luminex, Invitrogen, Dynal Biotech, Purdue University, Applera, Applied Biosystems, Celera Genomics

Ciphergen, MD Anderson Cancer Center, NIH, Lumera, Luminex, Invitrogen, Dynal Biotech, Purdue University, Applera, Applied Biosystems, Celera Genomics

Feb 18, 2005
Premium

Ciphergen and MD Anderson Cancer Center Sign Ovarian Cancer Biomarker Alliance

Ciphergen Diagnostics, a division of Ciphergen Biosystems, has signed a research and license agreement with the University of Texas MD Anderson Cancer Center to discover ovarian cancer biomarkers, the company said this week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Whirlwind Genetic Genealogy Year

Wired reports on how genetic genealogy's use in forensics has exploded in the year since an arrest in the Golden State Killer case was made.

Getting Through the Backlog

Retraction Watch reports that the increase in retracted papers at a journal is due to more resources there to tackle publication ethics.

Settlement After DNA Testing Questions

New York City has settled with a forensic scientist who was fired after questioning a DNA testing approach used by the medical examiner's office, the New York Times reports.

This Week in Nature

In Nature this week: technique for measuring replication fork movement, WINTHER trial results, and more.

Apr
30
Featured Webinar

Novel Methods for Improving De Novo Transcriptome Annotation with Long-Read Transcript Sequencing

Sponsored by
Lexogen

This webinar will discuss novel long-read transcript sequencing (LRTseq) methods for transcriptome annotation that could increase the efficiency and accuracy of future sequencing projects.

What's Popular?

In Proteomics & Protein Research

  1. Roche Partners with Biognosys, Caprion to Demonstrate Proteomics Readiness for Clinical Trials

    Premium

  2. Colon Cancer Biology, Treatment Clues Found in Proteogenomic Analysis

  3. MD Anderson, IsoPlexis Link T-cell Functionality to Immunotherapy Response in AML

    Premium

  4. Expedeon Posts 68 Percent Rise in 2018 Revenues

  5. Blood Protein Signature Reported for Severe Diabetic Kidney Disease

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.